Perceptive Advisors LLC
- SEC CIK
- 0001224962
- 最新申報
- 2026/8/14
2024 年第 3 季持倉
持倉截至 2024/9/30，2024/11/14 申報。只含多頭部位，變化是跟 2024 年第 2 季比股數。
- 持股檔數
- 102
- 較 2024 年第 2 季 −5
- 總值
- $46.6 億
- 較 2024 年第 2 季 +$5.18 億 (+12.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ACLXArcellx, Inc. | COMMON STOCK | 3,888,669 | $3.25 億 | 7.0% | −1,0700.0% | 減碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 2,979,235 | $3.05 億 | 6.5% | +430,158+16.9% | 加碼 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 28,057,456 | $3.00 億 | 6.4% | 00.0% | 不變 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 26,617,709 | $2.50 億 | 5.4% | +684,567+2.6% | 加碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 2,027,608 | $2.32 億 | 5.0% | +165,000+8.9% | 加碼 | 歷史 |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 3,560,214 | $1.87 億 | 4.0% | +113,635+3.3% | 加碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 6,315,933 | $1.82 億 | 3.9% | +3,882,208+159.5% | 加碼 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 3,204,976 | $1.62 億 | 3.5% | 00.0% | 不變 | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 1,622,215 | $1.19 億 | 2.5% | −94,192−5.5% | 減碼 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 2,015,007 | $1.18 億 | 2.5% | −90,629−4.3% | 減碼 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 1,699,987 | $1.08 億 | 2.3% | +978,610+135.7% | 加碼 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 6,282,290 | $1.00 億 | 2.2% | +2,348,983+59.7% | 加碼 | 歷史 |
| IMTXImmatics N.V. | SHS | 8,086,159 | $9,226 萬 | 2.0% | 00.0% | 不變 | 歷史 |
| EOLSEvolus, Inc. | COM | 5,356,622 | $8,678 萬 | 1.9% | −397,176−6.9% | 減碼 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 2,872,547 | $8,448 萬 | 1.8% | −158,471−5.2% | 減碼 | 歷史 |
| AORTArtivion, Inc. | COM | 2,793,703 | $7,437 萬 | 1.6% | 00.0% | 不變 | 歷史 |
| BHVNBiohaven Ltd. | COM | 1,485,232 | $7,422 萬 | 1.6% | 00.0% | 不變 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 6,485,420 | $7,140 萬 | 1.5% | 00.0% | 不變 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 782,844 | $7,035 萬 | 1.5% | +323,733+70.5% | 加碼 | 歷史 |
| APLTApplied Therapeutics, Inc. | COM | 8,005,000 | $6,804 萬 | 1.5% | 00.0% | 不變 | 歷史 |
| CRGXCARGO Therapeutics, Inc. | COM | 3,683,004 | $6,795 萬 | 1.5% | 00.0% | 不變 | 歷史 |
| IMVTImmunovant, Inc. | COM | 2,378,762 | $6,782 萬 | 1.5% | +454,976+23.7% | 加碼 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 1,164,035 | $6,698 萬 | 1.4% | +413,805+55.2% | 加碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 118,839 | $6,442 萬 | 1.4% | +103,239+661.8% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 2,812,665 | $6,399 萬 | 1.4% | +1,180,837+72.4% | 加碼 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 2,330,294 | $6,220 萬 | 1.3% | +473,877+25.5% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 1,374,563 | $6,186 萬 | 1.3% | +105,828+8.3% | 加碼 | 歷史 |
| MGTXMeiraGTx Holdings plc | COM | 12,581,103 | $5,243 萬 | 1.1% | +1,250,000+11.0% | 加碼 | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 9,275,851 | $5,000 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 1,714,806 | $4,920 萬 | 1.1% | +214,909+14.3% | 加碼 | 歷史 |
| SLDBSolid Biosciences Inc. | COM NEW | 6,906,646 | $4,814 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 1,296,416 | $4,264 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| ACRVAcrivon Therapeutics, Inc. | COMMON STOCK | 5,360,858 | $3,753 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 724,698 | $3,703 萬 | 0.8% | −751,505−50.9% | 減碼 | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 12,594,211 | $3,589 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| CELCCelcuity Inc. | COM | 2,362,279 | $3,522 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| PODDInsulet Corp | Stock | 142,269 | $3,311 萬 | 0.7% | +142,269 | 新進 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 1,235,187 | $3,027 萬 | 0.6% | +1,235,187 | 新進 | 歷史 |
| CTNMContineum Therapeutics, Inc. | CL A | 1,516,668 | $2,903 萬 | 0.6% | −50,000−3.2% | 減碼 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 3,324,468 | $2,892 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| ISRGIntuitive Surgical Inc | COM NEW | 58,119 | $2,855 萬 | 0.6% | −3,681−6.0% | 減碼 | 歷史 |
| NTRANatera, Inc. | COM | 220,000 | $2,793 萬 | 0.6% | −310,000−58.5% | 減碼 | 歷史 |
| CGONCG Oncology, Inc. | COM | 733,695 | $2,768 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| ZYMEZymeworks Inc. | COM | 2,180,020 | $2,736 萬 | 0.6% | +512,309+30.7% | 加碼 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 718,144 | $2,580 萬 | 0.6% | +718,144 | 新進 | 歷史 |
| ADGMAdagio Medical Holdings, Inc. | COM | 9,812,419 | $2,532 萬 | 0.5% | +9,812,419 | 新進 | 歷史 |
| ARVNArvinas, Inc. | COM | 1,027,749 | $2,531 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| PRCTPROCEPT BioRobotics Corp | COM | 315,659 | $2,529 萬 | 0.5% | +105,000+49.8% | 加碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 212,228 | $2,445 萬 | 0.5% | −437,681−67.3% | 減碼 | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | COM | 4,592,556 | $2,361 萬 | 0.5% | +2,046,675+80.4% | 加碼 | 歷史 |
| TILInstil Bio, Inc. | COM NEW | 345,545 | $2,326 萬 | 0.5% | +345,545 | 新進 | 歷史 |
| LIVNLivaNova PLC | SHS | 429,000 | $2,254 萬 | 0.5% | −15,000−3.4% | 減碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 692,263 | $2,218 萬 | 0.5% | −960,699−58.1% | 減碼 | 歷史 |
| MDTMedtronic plc | Stock | 245,332 | $2,209 萬 | 0.5% | −245,333−50.0% | 減碼 | 歷史 |
| ADMAAdma Biologics, Inc. | COM | 1,060,200 | $2,119 萬 | 0.5% | −1,710,800−61.7% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 524,930 | $2,067 萬 | 0.4% | −58,326−10.0% | 減碼 | 歷史 |
| ZBIOZenas BioPharma, Inc. | COM | 1,144,035 | $1,936 萬 | 0.4% | +1,144,035 | 新進 | 歷史 |
| IRONDisc Medicine, Inc. | COM | 387,017 | $1,902 萬 | 0.4% | −166,420−30.1% | 減碼 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 931,851 | $1,721 萬 | 0.4% | −314,746−25.2% | 減碼 | 歷史 |
| INBXInhibrx Biosciences, Inc. | COM | 1,064,026 | $1,666 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| RAPPRapport Therapeutics, Inc. | COM | 748,183 | $1,532 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| MRUSMerus N.V. | COM | 300,000 | $1,499 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 180,000 | $1,314 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ICLRIcon PLC | COM | 44,353 | $1,274 萬 | 0.3% | +13,103+41.9% | 加碼 | 歷史 |
| ARQTArcutis Biotherapeutics, Inc. | COM | 1,358,500 | $1,263 萬 | 0.3% | −200,000−12.8% | 減碼 | 歷史 |
| PEPGPepGen Inc. | COM | 1,410,438 | $1,206 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 511,226 | $1,202 萬 | 0.3% | −496,141−49.3% | 減碼 | 歷史 |
| XNCRXencor Inc | COM | 527,671 | $1,061 萬 | 0.2% | +527,671 | 新進 | 歷史 |
| VRCAVerrica Pharmaceuticals Inc. | COM | 7,099,182 | $1,029 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 847,745 | $978.3 萬 | 0.2% | +847,745 | 新進 | 歷史 |
| AVBPArriVent BioPharma, Inc. | COM | 415,000 | $975.3 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| EXASExact Sciences Corp | COM | 125,000 | $851.5 萬 | 0.2% | +125,000 | 新進 | 歷史 |
| EYPTEyePoint, Inc. | COM NEW | 1,037,274 | $828.8 萬 | 0.2% | +397,000+62.0% | 加碼 | 歷史 |
| ALLOAllogene Therapeutics, Inc. | COM | 2,725,000 | $763.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 2,125,649 | $688.7 萬 | 0.1% | +2,125,649 | 新進 | 歷史 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 255,994 | $579.3 萬 | 0.1% | −316,006−55.2% | 減碼 | 歷史 |
| VERUVeru Inc. | COM | 7,283,157 | $560.1 萬 | 0.1% | +219,880+3.1% | 加碼 | 歷史 |
| BBOTBridgeBio Oncology Therapeutics, Inc. | CL A ORD SHS | 500,000 | $522.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| BDSXBiodesix Inc | COM | 2,173,880 | $387.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| DTILPrecision Biosciences Inc | COM NEW | 426,293 | $382.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| MREOMereo BioPharma Group plc | SPON ADS | 815,722 | $335.3 萬 | 0.1% | −437,528−34.9% | 減碼 | 歷史 |
| LYRALyra Therapeutics, Inc. | COM | 12,757,562 | $327.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| NBTXNanobiotix S.A. | SPONSORED ADS | 555,066 | $319.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ABSIAbsci Corp | COM | 700,000 | $267.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| LONALeonaBio, Inc. | COM | 5,402,964 | $241.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM | 3,545,454 | $237.3 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| NVNOenVVeno Medical Corp | COMMON STOCK | 694,315 | $233.3 萬 | 0.1% | +71,000+11.4% | 加碼 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 46,213 | $218.7 萬 | <0.1% | +46,213 | 新進 | 歷史 |
| TRIBTrinity Biotech PLC | SPONS ADR NEW | 1,800,000 | $198.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 508,462 | $186.6 萬 | <0.1% | +508,462 | 新進 | 歷史 |
| IRTCiRhythm Holdings, Inc. | COM | 22,591 | $167.7 萬 | <0.1% | −12,614−35.8% | 減碼 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 34,852 | $153.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| LXEOLexeo Therapeutics, Inc. | COM | 139,835 | $126.4 萬 | <0.1% | +139,835 | 新進 | 歷史 |
| FATEFate Therapeutics Inc | COM | 345,575 | $121.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| OMICSingular Genomics Systems, Inc. | COM NEW | 50,896 | $79.8 萬 | <0.1% | −20,000−28.2% | 減碼 | 歷史 |
| KYTXKyverna Therapeutics, Inc. | COM | 150,000 | $73.3 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| FBRXForte Biosciences, Inc. | COM NEW | 95,742 | $53.5 萬 | <0.1% | −34,872−26.7% | 減碼依 1 比 25 拆股換算 | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 116,754 | $25.1 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| CMAXCareMax, Inc. | COMM STK | 100,000 | $17.0 萬 | <0.1% | −22,643−18.5% | 減碼 | 歷史 |
| RVMDWRevolution Medicines, Inc. | *W EXP 12/17/202 | 250,000 | $3.50 萬 | <0.1% | 00.0% | 不變 | 歷史 |
選擇權（5 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2024 年第 2 季之後清倉（18 檔）
2024 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 2 季股數 | 2024 年第 2 季市值 | 2024 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| CERECerevel Therapeutics Holdings, Inc. | COM | 10,794,876 | $4.41 億 | 10.7% | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 264,600 | $7,413 萬 | 1.8% | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 1,215,346 | $3,078 萬 | 0.7% | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 749,916 | $1,308 萬 | 0.3% | 歷史 |
| TEMTempus AI, Inc. | CL A | 275,000 | $962.5 萬 | 0.2% | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 800,000 | $754.4 萬 | 0.2% | 歷史 |
| SPRYARS Pharmaceuticals, Inc. | COM | 867,319 | $738.1 萬 | 0.2% | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 500,000 | $589.0 萬 | 0.1% | 歷史 |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 769,230 | $576.9 萬 | 0.1% | 歷史 |
| CABACabaletta Bio, Inc. | COM | 585,045 | $437.6 萬 | 0.1% | 歷史 |
| SKYESkye Bioscience, Inc. | COM NEW | 500,000 | $400.5 萬 | 0.1% | 歷史 |
| FHTXFoghorn Therapeutics Inc. | COM | 544,000 | $312.8 萬 | 0.1% | 歷史 |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 22,665 | $210.1 萬 | 0.1% | – |
| RVNCRevance Therapeutics, Inc. | COM | 600,000 | $154.2 萬 | <0.1% | 歷史 |
| EGRXEagle Pharmaceuticals, Inc. | COM | 173,365 | $97.1 萬 | <0.1% | 歷史 |
| VBIVVBI Vaccines Inc/BC | COM | 1,261,710 | $83.3 萬 | <0.1% | 歷史 |
| TCMDTactile Systems Technology Inc | COM | 62,639 | $74.8 萬 | <0.1% | 歷史 |
| AXGNAxogen, Inc. | COM | 30,421 | $22.0 萬 | <0.1% | 歷史 |